PLCE1 and urinary bladder cancer: Similarly, PLCE1 knockdown in bladder cancer reduces proliferating cell nuclear antigen and cyclin D1 in the bladder tumor xenograft, leading to significant inhibition of cell proliferation and cell cycle arrest [47].